Our latest 2014 update of the Metastatic non-small-cell lung cancer (NSCLC) Clinical Practice Guideline has just been published
Find out why you should join, what you will gain and how to apply to become a member of ESMO
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
OncologyPRO, our scientific information and education portal, has been given a fresh, new look...
E. van Cutsem comments two studies: NAPOLI-1, demonstrating improved survival for met pancreatic cancer patients with the novel drug MM-398; the SPARC analysis of MPACT, showing that the protein cannot be used as predictive marker for gemcitabine + nab-paclitaxel. There is still an unmet need to identify predictive markers for these patients.
22 Aug 2014
ESMO Award, ESMO Lifetime Achievement Awarda and Hamilton Fairley Award
22 Aug 2014
Updated version of the patient guide based on the 2013 ESMO Clinical Practice Guidelines is now available in English, Dutch, French, and Spanish.
21 Aug 2014
The programme uses a statistical model to accurately predict the likelihood that a patient carries IDH1 mutation
20 Aug 2014
The routine screening procedures are unlikely to benefit them
19 Aug 2014
The first biologic agent approved for patients with late-stage cervical cancer
18 Aug 2014
Multiplatform classification supports further biological discoveries and insights into novel therapeutic strategies
26 Sep - 30 Sep 2014
13 Nov - 16 Nov 2014
21 Nov - 22 Nov 2014
13 Mar - 14 Mar 2015
15 Apr - 18 Apr 2015
07 May - 09 May 2015